RIGL Stock Analysis: Buy, Sell, or Hold?
RIGL - Rigel Pharmaceuticals Inc. (New)
$35.61
-0.12 (-0.34%)
▼
5d:
+6.55%
30d:
+21.99%
90d:
+34.38%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When RIGL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: RIGL is 8.3% above its trading range ($32.89). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: RIGL is 8.3% above its trading range ($32.89). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$72.60
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$45.08
21.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RIGL is currently trading at $35.61, which is considered extended relative to its 30-day fair value range of $28.85 to $32.89. The stock's valuation (Forward PE: 7.5) is in line with its historical norms (7.8). Remarkably, the market is currently pricing in an annual earnings decline of 1.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, RIGL is in a downtrend. The price is approaching resistance at $36.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RIGL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $54.20 (+51.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RIGL is in a downtrend. The price is approaching resistance at $36.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RIGL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $54.20 (+51.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$28.85 -
$32.89
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
65.4%
Protect Your Profits
RIGL is technically overbought (RSI 73). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+8.3% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 51.7% below Wall St target ($54.20)
- CAUTION: Extended 8.3% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$28.85 -
$32.89
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$3.84
(10.8%)
Support & Resistance Levels
Support Level
$30.13
Resistance Level
$36.53
Current Trend
Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.48
Wall Street Target
$54.20
(+51.7%)
Revenue Growth (YoY)
10.3%
Earnings Growth (YoY)
-30.2%
Profit Margin
121.5%
Valuation Discount vs History
-1.4% cheaper
PE vs Historical
7.5 vs 7.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.4%
(market-implied from PE analysis)
1-Year Target
$35.23
(-1%)
2-Year Target
$34.74
(-3%)
3-Year Target
$34.25
(-4%)
3-Yr Target (if PE normalizes)
(PE: 7→8)
$35.74
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 63.9%)
$351.36
(+883%)
Base:
(SPY PE: 7.5, Growth: 63.9%)
$120.59
(+238%)
Bear:
(PE: 6.4, Growth: 63.9%)
$102.50
(+187%)
📈
Valuation based on Current Earnings
Trailing PE: 1.70 | Current EPS (TTM): $19.31
Bull Case
$18.10
(-49%)
Analyst growth -50.0%, PE expands to 1.9
Base Case
$16.46
(-54%)
Market implied -50.0%, PE stable at 1.7
Bear Case
$22.38
(-37%)
Severe decline -20.0%, PE contracts to 1.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.5 to 7.8
Stabilization Target:
$37.28
(+4.3%)
PE Expansion Potential:
+4.3%
Share & Embed Analysis
Last updated: June 23, 2026 3:53 PM ET
Data refreshes hourly during market hours. Next update: 4:53 PM
Data refreshes hourly during market hours. Next update: 4:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RIGL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Walter H Moos
SELL
4000 shares
2026-02-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 64 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 62 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 65 BUY |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 63 BUY |
Advanced RIGL Option Strategies
Professional options setups generated by AI based on today's RIGL price and gamma walls.
